Keywords: pfizer, 3rd-qtr, suffers, due, charges, dropping, exubera
Pfizer's 3rd-qtr suffers due to charges for dropping Exubera, generic competition
Article | 29 October 2007
New York, USA-based Pfizer, the world's largest prescription drugmaker by sales, posted a dismal set of third-quarter 2007 results, which were ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
